Last update 04 Aug 2025

KD6005

Overview

Basic Info

Drug Type
Biological products
Synonyms
KD 6005, KD-6005, KD6005
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal Diseases
Active Indication
Rheumatoid Arthritis
Inactive Indication-
Originator Organization
Shanghai Celgen Bio-pharmaceutical Co., Ltd.Shanghai Celgen Bio-pharmaceutical Co., Ltd.Shanghai Kangdai Biomedical Technology Co., Ltd.Shanghai Kangdai Biomedical Technology Co., Ltd.
Active Organization
Shanghai Celgen Bio-pharmaceutical Co., Ltd.Shanghai Celgen Bio-pharmaceutical Co., Ltd.Shanghai Kangdai Biomedical Technology Co., Ltd.Shanghai Kangdai Biomedical Technology Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with KD6005
NCT06213259
/ RecruitingPhase 1
A Phase 1, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Pharmacodynamics of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA).
100 Clinical Results associated with KD6005
Login to view more data
100 Translational Medicine associated with KD6005
Login to view more data
100 Patents (Medical) associated with KD6005
Login to view more data
100 Deals associated with KD6005
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Rheumatoid ArthritisPhase 1
China
Shanghai Celgen Bio-pharmaceutical Co., Ltd.Shanghai Celgen Bio-pharmaceutical Co., Ltd.
06 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free